Characteristics, Release, and Stability (Kinetics and Shelf-life) of Ciprofloxacin HCl-Alginate-Carrageenan Microspheres: Effects of Drug Concentration and Type of Lyoprotectant
Abstract
Tuberculosis, an infectious disease caused by the Mycobacterium tuberculosis bacteria, is one of the main causes of death worldwide. Alternative treatments are necessary due to the rising prevalence of medication resistance in Mycobacterium tuberculosis. Fluoroquinolones, such as ciprofloxacin HCl, are among these alternatives and are generally administered orally, but they have limitations. Therefore, pulmonary targeted inhalation delivery systems have been developed. Inhalation of microspheres enables deposition in the lungs at appropriate particle sizes. This study formulates ciprofloxacin HCl microspheres with an optimal ratio and concentration of polymer combination and crosslinker, aiming to determine the effect of drug concentration and lyoprotectant type on characteristics, release, and stability, including degradation kinetics and shelf life. The results showed that the ciprofloxacin HCl-alginate-carrageenan microsphere powder was yellowish-white, with smooth morphology, a yield percentage of 96.08% ± 0.84 – 97.00% ± 0.19, particle sizes below 5 µm, drug loading between 4.57% ± 0.13 – 6.76% ± 0.06, and entrapment efficiency ranging from 79.45% ± 2.53 – 90.80% ± 0.77. The powder had moisture content below 5% and excellent flow properties. Ciprofloxacin HCl release from microspheres at pH 7.4 for 30 hours was 84.55% ± 0.89 – 90.74% ± 0.22, following Korsmeyer-Peppas kinetics based on the Fickian diffusion mechanism. Ciprofloxacin HCl-alginate-carrageenan microspheres were stable and exhibited good shelf life. This study concluded that particle size, drug loading, entrapment efficiency, and drug release are all influenced by drug concentration, while moisture content and flow properties, with adequate shelf life, are influenced by the type of lyoprotectant.
References
Abdelghany, S., M. Alkhawaldeh, and H. S. Alkhatib (2017). Carrageenan-Stabilized Chitosan Alginate Nanoparticles Loaded with Ethionamide for the Treatment of Tuberculosis. Journal of Drug Delivery Science and Technology, 39; 442–449
Abdullah, M. F., T. Nuge, A. Andriyana, B. C. Ang, and F. Muhamad (2019). Core-Shell Fibers: Design, Roles, and Controllable Release Strategies in Tissue Engineering and Drug Delivery. Polymers, 11(12); 1–45
Abka-Khajouei, R., L. Tounsi, N. Shahabi, A. K. Patel, S. A. Ahmadi, and P. Matin (2022). Structures, Properties and Applications of Alginates: Review. Marine Drugs, 20; 364
Amiruddin, M. S. Rijal, and D. M. Hariyadi (2023). Effect of CaCl2 Crosslinker Concentration On The Characteristics, Release and Stability of Ciprofloxacin HCl-Alginate-Carrageenan Microspheres. Jurnal Farmasi dan Ilmu Kefarmasian Indonesia, 10(3); 312–323
Bayer Health Care Pharmaceuticals Inc. (2021). Ciprofloxacin Hydrochloride (Tablets and Oral Suspension) draft. US Food and Drug Administration
Bhangare, D., N. Rajput, T. Jadav, A. K. Sahu, R. K. Tekade, and P. Sengupta (2022). Systematic Strategies for Degradation Kinetic Study of Pharmaceuticals: An Issue of Utmost Importance Concerning Current Stability Analysis Practices. Journal of Analytical Science and Technology, 13(1); 7
Bruschi, M. L. (2015). Mathematical Models of Drug Release. In M. L. Bruschi (Ed.), Strategies to Modify the Drug Release from Pharmaceutical Systems. Elsevier, pages 63–86
Chaurasiya, B. and Y. Y. Zhao (2021). Dry Powder for Pulmonary Delivery: A Comprehensive Review. Pharmaceutics, 13(1); 1–28
Chotchindakun, K., J. Pekkoh, J. Ruangsuriya, K. Zheng, I. Unalan, and A. R. Boccaccini (2021). Fabrication and Characterization of Cinnamaldehyde-Loaded Mesoporous Bioactive Glass Nanoparticles/PHBV-Based Microspheres for Preventing Bacterial Infection and Promoting Bone Tissue Regeneration. Polymers, 13(11); 1794
Deliaz, M. F. (2023). The Effect of Drug-Polymer Ratio of Alginate-Carrageenan Combination on Characteristics, Release, Physical Stability, Antituberculosis Activity and Toxicity of Ciprofloxacin Microspheres. Master’s thesis, Universitas Airlangga
Deliaz, M. F., E. Hendradi, and D. M. Hariyadi (2023). The Effect of Polymer-Drug Ratio on Characteristics, Release and Stability of Ciprofloxacin-Alginate-Kappa Carrageenan Microspheres. Tropical Journal of Natural Product Research, 7; 5286–5291
DiPiro, J. T., G. C. Yee, S. T. Haines, T. D. Nolin, V. Ellingrod, and L. M. Posey (2023). DiPiro’s Pharmacotherapy: A Pathophysiologic Approach. McGraw Hill, 12th edition
Dominici, S., F. Marescotti, C. Sanmartin, M. Macaluso, I. Taglieri, F. Venturi, A. Zinnai, and M. S. Facioni (2022). Lactose: Characteristics, Food and Drug-Related Applications, and Its Possible Substitutions in Meeting the Needs of People with Lactose Intolerance. Foods, 11(10); 1486
Du, P., J. Du, and H. D. C. Smyth (2014). Evaluation of Granulated Lactose as a Carrier for DPI Formulations 1: Effect of Granule Size. AAPS PharmSciTech, 15(6); 1417–1428
Ebrahimi, A., M. Saffari, and T. Langrish (2017). Improving the Dissolution Rate of Hydrophobic Drugs through Encapsulation in Porous Lactose As a New Biocompatible Porous Carrier. International Journal of Pharmaceutics, 521(1–2); 204–213
El-Sherbiny, I. M., N. M. El-Baz, and M. H. Yacoub (2015). Inhaled Nano- and Microparticles for Drug Delivery. Global Cardiology Science and Practice, 2(1); 1–14
Fitriani, L., Z. Arif, U. Hasanah, and E. Zaini (2025). Enhancing the Solubility and Dissolution Rate of Tenoxicam through Co-Amorphous Formation with Meglumine by a Solvent Dropped Grinding Method. Science and Technology Indonesia, 10(1); 131–138
Gaber, D. M., N. Nafee, and O. Y. Abdallah (2021). Inhalable Nano-Embedded Microspheres As an Emerging Way for Local Treatment of Lung Carcinoma: Benefits, Methods of Preparation and Characterizaton. Editorial Committee, 1(1); 7
González-González, O., I. O. Ramirez, B. I. Ramirez, P. O’Connell, M. P. Ballesteros, J. J. Torrado, and D. R. Serrano (2022). Drug Stability: ICH Versus Accelerated Predictive Stability Studies. Pharmaceutics, 14(11); 2324
Hariyadi, D. M., T. Erawati, N. Rosita, G. Desanto, and A. Trinanda (2023). Influence of Polymer Combination Concentration on the Characteristics, In Vitro Release, and In Vivo Lung Deposition of Alginate-Carrageenan Microspheres Encapsulating Ciprofloxacin HCl. Indonesian Journal of Pharmacy, 34(1); 162–173
Hariyadi, D. M., E. Hendradi, and T. D. Kurniawan (2019). Alginate Microspheres Encapsulating Ciprofloxacin HCl: Characteristics, Release and Antibacterial Activity. International Journal of Pharma Research and Health Sciences, 7(4); 3020–3027
Hariyadi, D. M., E. Hendradi, M. Rahmadi, N. Bontong, E. Pudjadi, and N. Islam (2022). In-vitro Physicochemical Properties and Antibacterial Activity of Ciprofloxacin-Carragenan Inhalable Microspheres. Rasayan Journal of Chemistry, 15(1); 132–142
Hariyadi, D. M., T. Purwanti, and S. Adilla (2018). Influence of Crosslinker Concentration on the Characteristics of Erythropoietin-Alginate Microspheres. Journal of Pharmacy and Pharmacognosy Research, 6(4); 250–259
Hariyadi, D. M., T. Purwanti, and D. Wardani (2016). Stability of Freeze-Dried Ovalbumin-Alginate Microspheres with Different Lyoprotectants. Research Journal of Pharmacy and Technology, 9(1); 20–26
Heifets, L. B. and P. J. Lindholm-Levy (1987). Bacteriostatic and Bactericidal Activity of Ciprofloxacin and Ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium Complex. Tubercle, 68(4); 267–276
Horiba, I. (2016). A Guidebook to Particle Size Analysis. HORIBA Scientific, Kyoto, Japan. Available at: labinfo@horiba.com
Huang, R., H. Zhang, L. Lv, Y. Zhang, J. Li, H. Wang, and W. Gao (2023). Design of Gefitinib-Loaded PLGA Microspheres Via Microfluidics for Lung Cancer. Materials and Design, 234; 112336
Jelvehgari, M., A. Nokhodchi, M. Rezapour, and H. Valizadeh (2010). Effect of Formulation and Processing Variables on the Characteristics of Tolmetin Microspheres Prepared by Double Emulsion Solvent Diffusion Method. Indian Journal of Pharmaceutical Sciences, 72(1); 72–78
Jerome, A., M. Onda, and J. A. Aquino (2020). Evaluation of Factors Affecting the Microencapsulation of Mefenamic Acid with Cellulose Acetate Phthalate. Pharmaceutical Sciences Asia, 47(2); 130–141
Kalalo, T., A. Miatmoko, H. Tanojo, T. Erawati, D. M. Hariyadi, and N. Rosita (2022). Effect of Sodium Alginate Concentration on Characteristics, Stability and Drug Release of Inhalation Quercetin Microspheres. Jurnal Farmasi dan Ilmu Kefarmasian Indonesia, 9(2); 107–114
Kalman, H. (2021). Effect of Moisture Content on Flowability: Angle of Repose, Tilting Angle, and Hausner Ratio. Powder Technology, 393; 582–596
Karhale, A. A., H. S. Chaudhari, P. L. Ughade, D. T. Baviskar, and D. K. Jain (2012). Pulmonary Drug Delivery System. International Journal of PharmTech Research, 4(1); 293–305
Karunnanithy, V., N. H. B. Abdul Rahman, N. A. H. Abdullah, M. B. Fauzi, Y. Lokanathan, A. N. MinHwei, and M. Maarof (2024). Effectiveness of Lyoprotectants in Protein Stabilization During Lyophilization. Pharmaceutics, 16(10); 1–16
Kolesnyk, I. S. and A. Burban (2015). Alginate / κ-Carrageenan Microspheres and their Application for Protein Drugs Controlled Release. Chemistry and Chemical Technology, 9(4); 485–492
Kurniawan, M. F., D. Setyawan, and D. M. Hariyadi (2024). Quercetin in Drug Carriers: Polymer Composite, Physical Characteristics, and in Vitro Study. Science and Technology Indonesia, 9(2); 380–412
Lane, J. (2016). Powder Flow. United States Pharmacopeia, 30(6); 1–7
Lee, K. Y. and D. J. Mooney (2012). Alginate: Properties and Biomedical Applications. Progress in Polymer Science, 37(1); 106–126
Lengyel, M., N. Kállai-Szabó, V. Antal, A. J. Laki, and I. Antal (2019). Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery. Scientia Pharmaceutica, 87(3); 20
Li, W., J. Chen, S. Zhao, T. Huang, H. Ying, C. Trujillo, G. Molinaro, Z. Zhou, T. Jiang, W. Liu, L. Li, Y. Bai, P. Quan, Y. Ding, J. Hirvonen, G. Yin, H. A. Santos, J. Fan, and D. Liu (2022). High Drug-Loaded Microspheres Enabled by Controlled In-Droplet Precipitation Promote Functional Recovery After Spinal Cord Injury. Nature Communications, 13(1); 1262
Liempepas, A., M. Rahmadi, F. Ifadotunnikmah, and D. M. Hariyadi (2025). Effect of Sodium Alginate-Carrageenan Concentration in Rifampicin Pulmospheres on Physical Characteristics, Release, and Anti-Tuberculosis Activity. Science and Technology Indonesia, 10(3); 817–825
Mehta, P., C. Bothiraja, S. Kadam, and A. Pawar (2018). Potential of Dry Powder Inhalers for Tuberculosis Therapy: Facts, Fidelity and Future. Artificial Cells, Nanomedicine, and Biotechnology, 46(sup3); S791–S806
Parameswari, C. S., B. Manasa, K. Mounika, N. N. Sree, and M. Rajeswari (2024). Microspheres. International Journal of Pharmaceutical Sciences, 2(12); 502–519
Rowe, R. C., P. J. Sheskey, and S. C. Owen (2009). Handbook of Pharmaceutical Excipients. Pharmaceutical Press, London, 6th edition
Sacco, P., S. Pedroso-Santana, Y. Kumar, N. Joly, P. Martin, and P. Bizzaro (2021). Ionotropic Gelation of Chitosan Flat Structures and Potential Applications. Molecules, 26; 660
Saha, T., S. Sinha, R. Harfoot, and M. E. Quiñones-Mateu (2022). Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder. Pharmaceutics, 14(1420); 1–20
Scrivens, G., D. Clancy, and P. Gerst (2018). Theory and Fundamentals of Accelerated Predictive Stability (APS) Studies. In Accelerated Predictive Stability (APS): Fundamentals and Pharmaceutical Industry Practices. Elsevier Inc., pages 21–52
Shan, L., E. X. Tao, Q. H. Meng, W. X. Hou, K. Liu, H. C. Shang, J. B. Tang, and W. Zhang (2016). Formulation, Optimization, and Pharmacodynamic Evaluation of Chitosan/Phospholipid/β-Cyclodextrin Microspheres. Drug Design, Development and Therapy, 10; 417–429
Thai, T., B. Salisbury, and P. Zito (2022). Ciprofloxacin. StatPearls; 2022
Varela-Fernández, R., C. Bendicho-Lavilla, M. Martin-Pastor, R. H. Vanrell, M. I. Lema-Gesto, M. González-Barcia, and F. J. Otero-Espinar (2022). Design, Optimization, and in Vitro Characterization of Idebenone-Loaded PLGA Microspheres for LHON Treatment. International Journal of Pharmaceutics, 616; 121504
Verma, R., S. Verma, and K. Sokindra (2019). Microsphere-A Novel Drug Delivery System. Research Chronicle in Health Sciences, 5(1); 5–14
Wee, C. Y., Q. R. T. Lim, Y. Zhao, X. Xu, Z. Yang, D. Wang, and E. S. Thian (2023). Optimizing Fabrication Parameters Via Taguchi Method for Production of High Yield Hydroxyapatite Microsphere Scaffolds Using Drop-On-Demand Inkjet Method. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 111(11); 1938–1955
Wijaksana, A. (2022). The Effect of Alginate-Carrageenan Polymer Combination Concentration on the Release and Antibacterial Activity of Ciprofloxacin HCl Pulmospheres. Master’s thesis, Universitas Airlangga
World Health Organization (2024). Global Tuberculosis Report 2024. World Health Organization, Geneva, Switzerland
Wulandari, A. D., S. Sutriyo, and R. Rahmasari (2022). Synthesis Conditions and Characterization of Superparamagnetic Iron Oxide Nanoparticles with Oleic Acid Stabilizer. Journal of Advanced Pharmaceutical Technology and Research, 13(2); 89–94
Yadav, S. K., G. Khan, G. V. Bonde, M. Bansal, and B. Mishra (2018). Design, Optimization and Characterizations of Chitosan Fortified Calcium Alginate Microspheres for the Controlled Delivery of Dual Drugs. Artificial Cells, Nanomedicine and Biotechnology, 46(6); 1180–1193
Yang, T., S. Han, H. Xu, M. Ye, T. C. Liu, J. Liu, S. Lu, C. Liu, Y. Liu, and P. Zhou (2024). Improving Technofunctional Performance and Emulsion Stability of Ginsenoside Microcapsules by Using Maltodextrin-Inulin/lactose Composite Wall Materials. Powder Technology, 438; 1–13
Yu, F., T. Cui, C. Yang, X. Dai, and J. Ma (2019). κ-Carrageenan / Sodium Alginate Double-Network Hydrogel with Enhanced Mechanical Properties, Anti-Swelling, and Adsorption Capacity. Chemosphere, 237; 124417
Zhang, J., L. Wang, Y. Shen, L. Wan, K. Zhuang, X. Yang, C. Man, Q. Zhao, and Y. Jiang (2024). Effects of Different Reducing Carbohydrate Types on the Physicochemical Characteristics of Infant Formula Food Stored for Special Medical Purposes. Food Chemistry: X, 21; 101055
Authors

This work is licensed under a Creative Commons Attribution 4.0 International License.